Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

XORTX Appoints New Director

$XRTXPress releaseJul 29, 2026, 7:00 AM ETRead the release

XORTX Therapeutics appointed Depesh Narotam to its board of directors as an independent director effective July 27, 2026. Mr. Narotam brings over 20 years of financial services and debt financing expertise to the role, currently serving as a Mortgage Development Manager at Vancity.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.